Free Trial

QHSLab Q4 2024 Earnings Report

QHSLab logo
$0.20 0.00 (0.00%)
As of 04/4/2025

QHSLab EPS Results

Actual EPS
-$0.03
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

QHSLab Revenue Results

Actual Revenue
$0.63 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

QHSLab Announcement Details

Quarter
Q4 2024
Time
After Market Closes

Conference Call Resources

Remove Ads

QHSLab Earnings Headlines

Altucher: Turn $900 into $108,000 in just 12 months?
We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.
See More QHSLab Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like QHSLab? Sign up for Earnings360's daily newsletter to receive timely earnings updates on QHSLab and other key companies, straight to your email.

About QHSLab

QHSLab (OTCMKTS:USAQ), a medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine. It develops digital therapeutics and point of care solutions to support remote patient monitoring, address chronic care, and preventive medicine. The company provides quality health score lab expert system (QHSLab), a cloud-based SaaS system, which provides physicians and healthcare organizations with the ability to capture and store patient information electronically in a secure database; and distributes AllergiEnd, a diagnostic related product and allergen immunotherapy treatments to primary care physicians. Its products are designed to promote prevention, early detection, management, and reversal of chronic diseases. The company was formerly known as USA Equities Corp. and changed its name to QHSLab, Inc. in April 2022. QHSLab, Inc. has a strategic alliance with Medical License Factory, LLC. QHSLab, Inc. was incorporated in 1983 and is based in West Palm Beach, Florida.

View QHSLab Profile

More Earnings Resources from MarketBeat